EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome

Background Despite the advances in glioblastoma (GBM) treatment, the average life span of patients is 14 months. Therefore, it is urgent to identity biomarkers of prognosis, treatment response, or development of novel treatment strategies. We previously described the association of high epidermal gr...

Full description

Bibliographic Details
Main Authors:	Bruno Henrique Bressan da Costa, Aline Paixão Becker, Luciano Neder, Paola Gyuliane Gonçalves, Cristiane de Oliveira, Allan Dias Polverini, Carlos Afonso Clara, Gustavo Ramos Teixeira, Rui Manuel Reis, Lucas Tadeu Bidinotto
Format:	Article
Language:	English
Published:	Korean Society of Pathologists & the Korean Society for Cytopathology 2022-07-01
Series:	Journal of Pathology and Translational Medicine
Subjects:	egfl7 glioblastoma idh-wildtype pi3k-akt pathway notch pathway rap1 pathway
Online Access:	http://www.jpatholtm.org/upload/pdf/jptm-2022-04-22.pdf

Similar Items

Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
by: Dana M. Lewis, et al.
Published: (2022-04-01)

Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma
by: Yusuke Funakoshi, et al.
Published: (2021-05-01)

Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
by: Douglas A. Mata, et al.
Published: (2020-11-01)

A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
by: Wentao Feng, et al.
Published: (2023-04-01)

Non-Association of Driver Alterations in PTEN with Differential Gene Expression and Gene Methylation in IDH1 Wildtype Glioblastomas
by: Mrinmay Kumar Mallik, et al.
Published: (2023-01-01)

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
by: Yu-Qing Liu, et al.
Published: (2019-12-01)

Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma
by: Peng Du, et al.
Published: (2023-10-01)

Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial <i>IDH</i>-Wildtype Glioblastomas in Adults
by: Alessandro Moiraghi, et al.
Published: (2021-06-01)

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
by: Nguyen Quoc Khanh Le, et al.
Published: (2020-09-01)

Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
by: Christine Jungk, et al.
Published: (2019-01-01)

Magnetic resonance spectroscopic correlates of progression free and overall survival in “glioblastoma, IDH-wildtype, WHO grade-4”
by: Banu Sacli-Bilmez, et al.
Published: (2023-06-01)

microRNA-126 Is a Tumor Suppressor of Granulosa Cell Tumor Mediated by Its Host Gene EGFL7
by: Jiajie Tu, et al.
Published: (2019-06-01)

Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway
by: Fan Wu, et al.
Published: (2021-06-01)

Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
by: Seon-Jin Yoon, et al.
Published: (2020-12-01)

Clinicopathological and Molecular Characteristics of <i>IDH</i>-Wildtype Glioblastoma with <i>FGFR3::TACC3</i> Fusion
by: Hyunsik Bae, et al.
Published: (2024-01-01)

Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
by: Dandan Fan, et al.
Published: (2021-01-01)

Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series
by: Megan Parker, et al.
Published: (2023-08-01)

The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification)
by: Xuezhen Wang, et al.
Published: (2023-01-01)

<sup>18</sup>F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
by: Lena M. Mittlmeier, et al.
Published: (2021-06-01)

Prognostic Analysis of the IDH1 G105G (rs11554137) SNP in IDH-Wildtype Glioblastoma
by: Ayoub Saaid, et al.
Published: (2022-08-01)

Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
by: Nico Teske, et al.
Published: (2023-03-01)

Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma <i>IDH</i> Wildtype
by: Elham Kashani, et al.
Published: (2022-10-01)

EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors
by: Nevenka Dudvarski Stanković, et al.
Published: (2018-09-01)

Familial glioblastoma clustering in adult patients: a case report of two non-twin siblings and review of the literature
by: Sander C, et al.
Published: (2019-07-01)

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma
by: Haihui Jiang, et al.
Published: (2021-05-01)

Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review
by: Giuseppe Broggi, et al.
Published: (2022-02-01)

DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers
by: Maria Caffo, et al.
Published: (2024-04-01)

Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification
by: Alexandre Vallée, et al.
Published: (2021-05-01)

Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery
by: Rosa Maria Gerardi, et al.
Published: (2023-02-01)

IDH1 regulates the expression of interferon pathway-related gene IFIT3
by: TANG Wan-jun, PENG Xiao-zhong, HAN Wei
Published: (2021-07-01)

NOTCH Signaling Pathway Regulates Glioma Stem-like Cell Proliferation and Self-renewal Abilities via PI3K/AKT Activity
by: ZHANG Xin, et al.
Published: (2018-09-01)

Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
by: Rishan Thimma Sudarsan, et al.
Published: (2023-04-01)

egfl6 expression in the pharyngeal pouch is dispensable for craniofacial development
by: Sil Jin, et al.
Published: (2021-09-01)

Let Me See: Correlation between 5-ALA Fluorescence and Molecular Pathways in Glioblastoma: A Single Center Experience
by: Francesco Maria Calamo Specchia, et al.
Published: (2021-06-01)

Role of Notch Signaling Pathway in Glioblastoma Multiforme Pathogenesis
by: Riccardo Bazzoni, et al.
Published: (2019-03-01)

Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis
by: Lan Xiaolei, et al.
Published: (2019-12-01)

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
by: Magda Sayed Mahmoud, et al.
Published: (2024-03-01)

Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type
by: Cristian Ionut Orasanu, et al.
Published: (2022-12-01)

Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification
by: María del Mar Álvarez-Torres, et al.
Published: (2022-01-01)

The importance of IDH1, ATRX and WT-1 mutations in glioblastoma
by: Gülsün Gülten, et al.
Published: (2020-07-01)